Vladislav Sandler

Vladislav Sandler

Fortune : 941 588 $ au 31/07/2026

61 ans
Health Technology
Consumer Services

Profil

Vladislav Sandler is the founder of HemoGenyx Pharmaceuticals Plc, founded in 2012, holding the title of Chief Executive Officer & Executive Director since 2017.
Dr. Sandler is also the founder of Hemogenyx Pharmaceuticals LLC..
Dr. Sandler currently holds the position of Director at Hemogenyx UK Ltd. since 2017.
Since 2019, Dr. Sandler has been Chief Executive & Scientific Officer at Immugenyx LLC.
Dr. Sandler is an Assistant Professor at the State University of New York at Downstate Medical Center.
Dr. Sandler is a Member of The International Society for Stem Cell Research.
Dr. Sandler earned a doctorate degree from the University of British Columbia.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2025 113 861 ( 1,67 % ) 941 588 $ 31/07/2026

Postes actifs de Vladislav Sandler

SociétésPosteDébut
HEMOGENYX PHARMACEUTICALS PLC Fondateur 01/01/2012
Fondateur -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil 04/10/2017
Directeur Général 01/01/2019

Formation de Vladislav Sandler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

38

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Vladislav Sandler
🔇